WHO Launches Global Blueprint to Combat Rising Fungal Diseases and Antifungal Resistance
4 sources · 64d ago
The Science of Tick Prevention: Alpha-Gal, New Vaccines, and How to Protect Yourself in 2026
6 sources · 75d ago
How Scientists Are Deploying Two Experimental Drugs Against the Rare Bundibugyo Ebola Strain
7 sources · 74d ago
Blindspot
Important stories the mainstream barely covered
High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.
DEA Begins Formal Hearing on Rescheduling Marijuana to Schedule III
The Drug Enforcement Administration has opened formal administrative hearings to consider moving marijuana from Schedule I to Schedule III under the Controlled Substances Act. The landmark proceedings will weigh medical evidence against enforcement concerns, potentially reshaping federal drug policy, banking, and criminal justice.
France Confirms First Ebola Case Linked to Deadly Congo Outbreak
A doctor returning from a humanitarian mission in the Democratic Republic of Congo has tested positive for the rare Bundibugyo strain of Ebola in Paris. Health officials emphasize the global risk remains low, though the outbreak in Central Africa continues to escalate rapidly.
Chemours to Pay $450 Million in First Federal Settlement Over PFAS 'Forever Chemicals'
The EPA and DOJ have reached a landmark $450 million settlement with chemical manufacturer Chemours over illegal discharges of toxic PFAS into waterways across three states. The agreement requires the company to fund drinking water cleanups and pollution controls while allowing continued production for military and industrial uses.




